Hidehiko Furukawa

5.5k citations

34 papers · 3.4k indexed · h-index 24

Cardiology and Cardiovascular Medicine top 1%
Molecular Biology top 10%
Endocrinology, Diabetes and Metabolism top 1%
Cancer Research top 2%
Organic Chemistry top 5%

Co-authors: Mitsuru Ono Tetsuya Shimizugawa Ryuta Koishi Yukio Ando Mitsuru Shimamura Kenichi Yoshida Toshinori Agatsuma Hiroaki Yasumo
Topics: HIV Research and Treatment (8 papers)Lipid metabolism and disorders (8 papers)HIV/AIDS drug development and treatment (8 papers)
Cited by: Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Cancer Research
Journals: Nucleic Acids Research Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: Japan Germany United States

In The Last Decade

Hidehiko Furukawa

34 papers receiving 3.3k citations

Peers

Countries citing papers authored by Hidehiko Furukawa

Since Specialization

Citations

This map shows the geographic impact of Hidehiko Furukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidehiko Furukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidehiko Furukawa more than expected).

Fields of papers citing papers by Hidehiko Furukawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidehiko Furukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidehiko Furukawa. The network helps show where Hidehiko Furukawa may publish in the future.

Co-authorship network of co-authors of Hidehiko Furukawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hidehiko Furukawa. A scholar is included among the top collaborators of Hidehiko Furukawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidehiko Furukawa. Hidehiko Furukawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Adenosine Receptor Signaling and Metabolism on Pathophysiology in Patients with Chronic Heart Failure 2007 ·Hypertension Research ·Masanori Asakura,Hiroshi Asanuma,Jiyoong Kim,Yulin Liao,Kenji Nakamaru,Masashi Fujita,Kazuo Komamura,Tadashi Isomura,Hidehiko Furukawa,Hitonobu Tomoike,Masafumi Kitakaze	45
2	Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents 2005 ·Bioorganic & Medicinal Chemistry Letters ·Masao Yoshida,Ichiro Hayakawa,Noriyuki Hayashi,Toshinori Agatsuma,(unknown),(unknown),(unknown),Kumiko Koyama,Hidehiko Furukawa,Shinichi Kurakata,Yuichi Sugano	177
3	Thienopyridine and benzofuran derivatives as potent anti-tumor agents possessing different structure–activity relationships 2004 ·Bioorganic & Medicinal Chemistry Letters ·Ichiro Hayakawa,(unknown),Toshinori Agatsuma,Hidehiko Furukawa,Yuichi Sugano	109
4	A library synthesis of 4-hydroxy-3-methyl-6-phenylbenzofuran-2-carboxylic acid ethyl ester derivatives as anti-tumor agents 2004 ·Bioorganic & Medicinal Chemistry Letters ·Ichiro Hayakawa,(unknown),Toshinori Agatsuma,Hidehiko Furukawa,Shunji Naruto,Yuichi Sugano	46
5	Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor 2004 ·Biochemical and Biophysical Research Communications ·Mitsuru Shimamura,Morihiro Matsuda,Yukio Ando,Ryuta Koishi,Hiroaki Yasumo,Hidehiko Furukawa,Iichiro Shimomura	71
6	Identification of 2′-Phosphodiesterase, Which Plays a Role in the 2-5A System Regulated by Interferon 2004 ·Journal of Biological Chemistry ·Kazuishi Kubota,(unknown),Toshiaki Ohtsuka,(unknown),Junko Kawaguchi,Yoko Fujita,(unknown),Ayako Hara,(unknown),Hidehiko Furukawa,Hideyuki Haruyama,Kimihisa Ichikawa,Makoto Yamashita,Tatsuji Matsuoka,Yasuteru Iijima	63
7	Jun Dimerization Protein 2 (JDP2), a Member of the AP-1 Family of Transcription Factor, Mediates Osteoclast Differentiation Induced by RANKL 2003 ·The Journal of Experimental Medicine ·Reimi Kawaida,Toshiaki Ohtsuka,(unknown),Tohru Takahashi,Yuho Kadono,Hiromi Oda,Atsuhiko Hikita,Kozo Nakamura,Sakae Tanaka,Hidehiko Furukawa	70
8	Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes 2003 ·Biochemical and Biophysical Research Communications ·Mitsuru Shimamura,Morihiro Matsuda,Sachiko Kobayashi,Yukio Ando,Mitsuru Ono,Ryuta Koishi,Hidehiko Furukawa,Makoto Makishima,Iichiro Shimomura	99
9	Protein Region Important for Regulation of Lipid Metabolism in Angiopoietin-like 3 (ANGPTL3) 2003 ·Journal of Biological Chemistry ·Mitsuru Ono,Tetsuya Shimizugawa,Mitsuru Shimamura,Kenichi Yoshida,(unknown),Yukio Ando,Ryuta Koishi,Hidehiko Furukawa	182
10	An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis 2003 ·Nature Genetics ·Shinya Tokuhiro,Ryo Yamada,Xiaotian Chang,Akari Suzuki,Yuta Kochi,Tetsuji Sawada,M. Suzuki,Miyuki Nagasaki,Masahiko Ohtsuki,Mitsuru Ono,Hidehiko Furukawa,Masakazu Nagashima,Shinichi Yoshino,Akihiko Mabuchi,Akihiro Sekine,Susumu Saito,Atsushi Takahashi,Tatsuhiko Tsunoda,Yusuke Nakamura,Kazuhiko Yamamoto	488
11	4-Hydroxy-3-methyl-6-phenylbenzofuran-2-carboxylic acid ethyl ester derivatives as potent anti-tumor agents 2003 ·Bioorganic & Medicinal Chemistry Letters ·Ichiro Hayakawa,(unknown),Toshinori Agatsuma,Hidehiko Furukawa,Shunji Naruto,Yuichi Sugano	91
12	Effects on RNA Interference in Gene Expression (RNAi) in Cultured Mammalian Cells of Mismatches and the Introduction of Chemical Modifications at the 3′-Ends of siRNAs 2002 ·Antisense and Nucleic Acid Drug Development ·(unknown),Toshiaki Ohtsuka,Reimi Kawaida,Makoto Koizumi,Koji Morita,Hidehiko Furukawa,Takeshi Imanishi,Makoto Miyagishi,Kazunari Taira	85
13	Angptl3 regulates lipid metabolism in mice 2002 ·Nature Genetics ·Ryuta Koishi,Yukio Ando,Mitsuru Ono,Mitsuru Shimamura,Hiroaki Yasumo,Toshihiko Fujiwara,Hiroyoshi Horikoshi,Hidehiko Furukawa	344
14	Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase 2002 ·Journal of Lipid Research ·Kenichi Yoshida,Tetsuya Shimizugawa,Mitsuru Ono,Hidehiko Furukawa	303
15	Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3′- and 5′-end-modification, with anti-HIV-1 activity 1998 ·Bioorganic & Medicinal Chemistry ·Makoto Koizumi,(unknown),Hitoshi Hotoda,(unknown),Hidehiko Furukawa,Toshinori Agatsuma,Takashi Nishigaki,Koji Abe,Toshiyuki Kosaka,Shinya Tsutsumi,Junko Sone,Masakatsu Kaneko,Satoshi Kimura,Kaoru Shimada	18
16	Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288 1997 ·Antiviral Research ·Toshinori Agatsuma,Kohji Abe,Hidehiko Furukawa,(unknown),Makoto Koizumi,Hitoshi Hotoda,Masakatsu Kaneko	11
17	Biologically active oligodeoxyribonucleotides—IX.1 Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3′- and 5′-end-modification 1997 ·Bioorganic & Medicinal Chemistry ·Makoto Koizumi,(unknown),Hitoshi Hotoda,(unknown),(unknown),Hidehiko Furukawa,Toshinori Agatsuma,Takashi Nishigaki,Koji Abe,Toshiyuki Kosaka,Shinya Tsutsumi,Junko Sone,(unknown),Satoshi Kimura,Kaoru Shimada	36
18	Guanine-rich oligonucleotide modified at the 5′ terminal by dimethoxytrityl residue inhibits HIV-1 replication by specific interaction with the envelope glycoprotein 1996 ·Antiviral Research ·Toshinori Agatsuma,(unknown),Hidehiko Furukawa,Takashi Nishigaki	12
19	Mechanism of inhibition of HIV-1 infectionin vitroby guanine-rich oligonucleotides modified at the 5′ terminal by dimethoxytrityl residue 1994 ·Nucleic Acids Research ·Hidehiko Furukawa,(unknown),Toshinori Agatsuma,(unknown),Satoshi Kimura,Kaoru Shimada	16
20	Genomic organization of the human homologue of the rat pancreatic elastase I gene 1992 ·DNA sequence ·Ichiro Kawashima,Tokio Tani,(unknown),(unknown),(unknown),Hidehiko Furukawa,Yo Takiguchi	12

About Hidehiko Furukawa

Hidehiko Furukawa is a scholar working on Virology, Cardiology and Cardiovascular Medicine and Physiology, having authored 34 papers that have together received 3.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), Lipid metabolism and disorders (8 papers) and HIV/AIDS drug development and treatment (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.5k citations), Endocrinology, Diabetes and Metabolism (907 citations) and Cancer Research (672 citations). Hidehiko Furukawa has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Mitsuru Ono, Tetsuya Shimizugawa, Ryuta Koishi, Yukio Ando, Mitsuru Shimamura, Kenichi Yoshida, Toshinori Agatsuma, Hiroaki Yasumo, Yuichi Sugano and Ichiro Hayakawa. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact